PD-Rx Pharmaceuticals, Inc. (PDRX) Research

PD-Rx Pharmaceuticals, Inc. specializes in the pre-packaging and distribution of pharmaceutical products for the United States healthcare sector. The company supplies an extensive catalog of approximately 2,600 ready-to-dispense medications, ranging from topical treatments like creams and ointments to specialized ophthalmics, otics, oral liquids, and suspensions. In addition to its product offerings, PD-Rx provides innovative solutions like PD-Rx Net, an online platform that streamlines prescription management by enabling healthcare providers to track medications dispensed directly at the point of care and generate necessary labels for on-site filling. They also offer a practical manual dispensing system, which includes 10 record-keeping labels neatly paired with 10 bottle trays, specifically designed for convenient use by physicians who dispense prescriptions. The company further supports its clientele with professional assistance from a team of pharmacists and physicians. A key service is their pharmaceutical sampling program, which is structured to help Managed Care Organizations (MCOs) reduce medication costs, while simultaneously allowing medical professionals to offer complimentary, pre-filled prescriptions to their patients. PD-Rx Pharmaceuticals, Inc. caters to a diverse customer base, including individual physicians, retail pharmacies, and medical clinics. Established in 1986, the company is headquartered in Oklahoma City, Oklahoma.

Market snapshot

Symbol
PDRX
Price
$3.35
Day change
0.00%
Market cap
$5.7M
P/E ratio
-20.10x
52-week range
2.41-3.35
Sector
Healthcare
Industry
Medical - Distribution

Peer companies

  • Captiva Verde Wellness Corp. (CPIVF)
  • Fuse Medical, Inc. (FZMD)
  • Interpace Biosciences, Inc. (IDXG)
  • Metawells Oil & Gas Inc. (KOSK)
  • Mountain Valley MD Holdings Inc. (MVMDF)
  • REMSleep Holdings, Inc. (RMSL)
  • Rennova Health, Inc. (RNVA)
  • Rapid Nutrition PLC (RPNRF)

Open PD-Rx Pharmaceuticals, Inc. (PDRX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.